Hepatoprotective Effect of Xymedon and its Conjugate with L-ascorbic Acid during Poisoning of Mice with a Semilethal Dose of Paracetamol
Main Article Content
Abstract
There is currently an urgent need to develop effective therapies aimed at preventing the consequences of drug-induced liver injury (DILI). In this context, our study focused on assessing the hepatoprotective effect of pyrimidine derivatives of xymedon (1,2-dihydro-4,6-dimethyl-1-(2- hydroxyethyl)-pyrimidin-2-one) and its conjugate with L-ascorbic acid in a mouse model of paracetamol (acetaminophen) poisoning. ICR (CD-1) mice were treated with a single oral LD50 dose of paracetamol (425 mg/kg), followed by intraperitoneal injections of various doses of the test compounds at various doses half an hour later. The animals` survival was monitored for 5 days. On the day 6, biochemical and histopathological evaluations of the effects of the test compounds were conducted. Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities were analyzed. Malondialdehyde (MDA) levels in blood and liver tissue were also determined. Xymedon attenuated the toxic effects of paracetamol on the liver, improving animal survival and enhancing the macro- and micro-structure of the liver, normalizing the biochemical indicator of liver condition ALT and the serum marker of oxidative stress MDA. The conjugate of xymedon with L-ascorbic acid exhibited a more pronounced hepatoprotective effect compared to the native xymedon molecule.
Article Details
References
- Allison, R., Guraka, A., Shawa, I. T., Tripathi, G., Moritz, W., Kermanizadeh, A. (2023). Drug induced liver injury–a 2023 update. Journal of Toxicology and Environmental Health, Part B, 26(8), 442-467. DOI
- Li, X., Tang, J., Mao, Y. (2022) Incidence and risk factors of drug‐induced liver injury. Liver International, 42(9), 1999-2014. DOI
- Ivashkin, V.T., Baranovsky, A.Yu., Raikhelson, K.L., Palgova, L.K., Maevskaya, M.V., Kondrashina, E.A., Marchenko, N.V., Nekrasova, T.P., Nikitin, I.G. (2019) Drug-Induced Liver Injuries (Clinical Guidelines for Physicians). Russian Journal of Gastroenterology, Hepatology, Coloproctology, 29(1), 85-115. DOI
- Devarbhavi, H., Asrani, S.K., Arab, J.P., Nartey, Y.A., Pose, E., Kamath, P.S. (2023) Global burden of liver disease: 2023 update. Journal of hepatology, 79(2), 516-537. DOI
- Bavia, L., Guiloski, I.C., Carvalho Carneiro, M., Prodocimo, M.M. (2023). Different mice strains in biomarker responses to toxic agents: the example of acetaminophen. In Biomarkers in Toxicology (V.B. Patel, V.R. Preedy, R. Rajendram eds.). Springer, Cham, pp. 1111-1132. DOI
- Jaeschke, H., Akakpo, J.Y., Umbaugh, D.S., Ramachandran, A. (2020) Novel therapeutic approaches against acetaminophen-induced liver injury and acute liver failure. Toxicological Sciences, 174(2), 159-167. DOI
- Bibik E.Yu., Shipilova N.V., Krivokolysko B.S., Semenido E.A., Burdeynaya A.A. (2019) Features of the pharmacological properties of modern hepatoprotectors. Morfologicheskij al`manax imeni V.G. Koveshnikova, 17(4), 101-110.
- Natarajan, R., Anthoni Samy, H.N., Sivaperuman, A., Subramani, A. (2023) Structure-activity relationships of pyrimidine derivatives and their biological activity-a review. Medicinal Chemistry, 19(1), 10-30. DOI
- Vyshtakalyuk, A.B., Semenov, V.E., Zobov, V.V., Galyametdinova, I.V., Gumarova, L.F., Parfenov, A.A., Nazarov, N.G., Lenina, O.A., Kondrashova, S.A., Latypov, Sh.K., Cherepnev, G.V., Shashyn, M.S., Reznic, V.S. (2017) Synthesis and primary evaluation of the hepatoprotective properties of novel pyrimidine derivatives. Russian Journal of Bioorganic Chemistry, 43(5), 604-611. DOI
- Reznik, V.S., Pashkurov, N.G. (1966) Reactions of pyrimidinols and pyrimidinethiols with 2-chloroethanol and with 2-chloro-1-propanol. Bulletin of the Academy of Sciences of the USSR, Division of Chemical Science, 15(9), 1554-1557. DOI
- Maes, M., Vinken, M., Jaeschke, H. (2016) Experimental models of hepatotoxicity related to acute liver failure. Toxicology and applied pharmacology, 290, 86-97. DOI
- McGill, M.R., Williams, C.D., Xie, Y., Ramachandran, A., Jaeschke, H. (2012) Acetaminophen-induced liver injury in rats and mice: comparison of protein adducts, mitochondrial dysfunction, and oxidative stress in the mechanism of toxicity. Toxicology and applied pharmacology, 264(3), 387-394. DOI
- Pavlova, O.N., Gulenko, O.N., Karimova, R.G., Boriskin, P.V., Devyatkin, A.A., Nikitin, A.G., Toropovsky, A. N. (2019) Interrelation of the distribution of concentration of the little dialdehyde in the serum of the blood and tissues of small animals. Scientific Notes Kazan Bauman State Academy of Veterinary Medicine, 238(2), 150-154. DOI
- Kane, A.E., Mitchell, S.J., Mach, J., Huizer-Pajkos, A., McKenzie, C., Jones, B., Cogger, V., Le Couteur, D.G., de Cabo, R., Hilmer, S.N. (2016) Acetaminophen hepatotoxicity in mice: effect of age, frailty and exposure type. Experimental gerontology, 73, 95-106. DOI
- Kalas, M.A., Chavez, L., Leon, M., Taweesedt, P.T., Surani, S. (2021) Abnormal liver enzymes: A review for clinicians. World journal of hepatology, 13(11), 1688-1698. DOI
- Serfilippi, L.M., Stackhouse Pallman, D.R., Russell, B., Spainhour, C.B. (2003). Serum clinical chemistry and hematology reference values in outbred stocks of albino mice from three commonly used vendors and two inbred strains of albino mice. Journal of the American Association for Laboratory Animal Science, 42(3), 46-52.
- Tsikas, D. (2017) Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: Analytical and biological challenges. Analytical biochemistry, 524, 13-30. DOI
- Vyshtakalyuk, A.B., Semenov, V.E., Sudakov, I.A., Bushmeleva, K.N., Gumarova, L.F., Parfenov, A.A., Nazarov, N.G., Galyametdinova, I.V., Zobov, V.V. (2018) Xymedon conjugate with biogenic acids. Antioxidant properties of a conjugate of Xymedon with l-ascorbic acid. Russian Chemical Bulletin, 67(4), 705-711. DOI
- Randle, L.E., Goldring, C.E.P., Benson, C.A., Metcalfe, P.N., Kitteringham, N.R., Park, B.K., Williams, D.P. (2008) Investigation of the effect of a panel of model hepatotoxins on the Nrf2-Keap1 defence response pathway in CD-1 mice. Toxicology, 243(3), 249-260. DOI
- Slabnov Y.D., Cherepnev G.V., Karimova F.G., Garaev R.S. (1998) Effect of pyrimidine derivatives on adenylate cyclase system of immunocompetent cell regulationin vitro. Bulletin of Experimental Biology and Medicine, 125(6), 588-590. DOI
- Beavo, J.A., Brunton, L.L. (2002) Cyclic nucleotide research – still expanding after half a century. Nature reviews Molecular cell biology, 3(9), 710-717. DOI
- Rivas, C.I., Zúñiga, F.A., Salas-Burgos, A., Mardones, L., Ormazabal, V., Vera, J.C. (2008) Vitamin C transporters. Journal of Physiology and Biochemistry, 64(4), 357-375. DOI
- Harrison, F.E., May, J.M. (2009) Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2. Free Radical Biology and Medicine, 46(6), 719-730. DOI
- Moteki, H., Kimura, M., Sunaga, K., Tsuda, T., Ogihara, M. (2013) Signal transduction mechanism for potentiation by α1-and β2-adrenoceptor agonists of L-ascorbic acid-induced DNA synthesis and proliferation in primary cultures of adult rat hepatocytes. European journal of pharmacology, 700(1-3), 2-12. DOI
- Kimura, M., Moteki, H., Uchida, M., Natsume, H., Ogihara, M. (2014) L-ascorbic acid-and L-ascorbic acid 2-glucoside accelerate in vivo liver regeneration and lower serum alanine aminotransaminase activity in 70% partially hepatectomized rats. Biological and Pharmaceutical Bulletin, 37(4), 597-603. DOI
- Roomi, M.W., Kalinovsky, T., Ivanov, V., Rath, M., Niedzwiecki, A. (2008) A nutrient mixture prevents acetaminophen hepatic and renal toxicity in ICR mice. Human & experimental toxicology, 27(3), 223-230. DOI
- Hargreaves, R.J., Evans, J.G., Pelling, D., Butterworth, K.R. (1982) Studies on the effects of l-ascorbic acid on acetaminophen-induced hepatotoxicity: II. An in vivo assessment in mice of the protection afforded by various dosage forms of ascorbate. Toxicology and Applied Pharmacology, 64(3), 380-392. DOI
- Mironov, A.N., Bunyatyan, N.D., Vasil’ev, A.N., Verstakova, O.L., Zhuravleva, M.V., Lepakhin, V.K., Korobov, N.V., Merkulov, V.A., Orekhov, S.N., Sakaeva, I.V., Uteshev, D.B., Yavorskii, A.N. (2012) Rukovodstvo po Provedeniyu Doklinicheskikh Issledovanii Lekarstvennykh Sredstv [Guidelines on Preclinical Trials of Medicinal Agents]. Grif i K, Moscow, 944 pp.